% Expired Patents = 80.0

Forward Citations = 55

Loading Chart...

2 inventors (with patents filed for the assignee):

Joseph Schwarz (5 out of 8 patents)

Michael Weisspapir (4 out of 6 patents)

5 patents: Sort by Forward Citations

1. 8097646 - Ophthalmic preparation containing menthyl ester of indomethacin (2012-01-17),

2. 7781429 - Vehicle for topical delivery of anti-inflammatory compounds (2010-08-24),

3. 7153888 - Stabilization of benzoyl peroxide in solution (2006-12-26),

4. 7138394 - Vehicle for topical delivery of anti-inflammatory compounds (2006-11-21),

5. 6117415 - Toothpaste comprising bioadhesive submicron emulsion for improved (2000-09-12),

Company Overview

AlphaRx, Inc. is a pharmaceutical company dedicated to developing innovative therapies to improve patient outcomes. With a focus on novel drug delivery systems, AlphaRx strives to address unmet medical needs and provide better alternatives for patients and healthcare providers. Through research and development, AlphaRx is committed to advancing healthcare and making a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#593 in Hong Kong

#5,255 in China

Hong Kong, China

Alpharx, Inc.

Forward Citations = 55

2 inventors:

Joseph Schwarz (5 out of 8 patents)

Michael Weisspapir (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alpharx, Inc.. Retrieved from https://idiyas.com/company/alpharx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]